LeMaitre Q4 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq reach record closing highs as focus pivots to earnings
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, Offers Guidance
February 27, 2024 4:57 PM ESTLemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $49 million versus the consensus estimate of $49.01 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2024 EPS of $0.36-$0.41, versus the consensus of $0.34.... More



